Moderate Renal Impairment (CrCl 30-50 mL/Min) Clinical Trials

Moderate Renal Impairment (CrCl 30-50 mL/Min)

Explore clinical trials studying Moderate Renal Impairment (CrCl 30-50 mL/Min). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Moderate Renal Impairment (CrCl 30-50 mL/Min) trial results

Completed

NCT01184989

Conditions: Arthroplasty, Replacement, Moderate Renal Impairment (CrCl 30-50 mL/Min), Prevention of Venous Thromboembolism
Locations: 1160.86.43001 Boehringer Ingelheim Investigational Site Graz, Austria

1160.86.43003 Boehringer Ingelheim Investigational Site Vienna, Austria

1160.86.01001 Boehringer Ingelheim Investigational Site Red Deer, Alberta, Canada

1160.86.01002 Boehringer Ingelheim Investigational Site Halifax, Nova Scotia, Canada

Moderate Renal Impairment (CrCl 30-50 mL/Min)